Royal Bank of Canada’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12M | Sell |
425,600
-199,400
| -32% | -$5.31M | ﹤0.01% | 1792 |
|
|
2025
Q4 | $15.6M | Sell |
625,000
-659,900
| -51% | -$16.6M | ﹤0.01% | 1663 |
|
|
2025
Q3 | $32.7M | Buy |
1,284,900
+73,300
| +6% | +$1.81M | 0.01% | 1268 |
|
|
2025
Q2 | $29.4M | Sell |
1,211,600
-1,340,000
| -53% | -$31.3M | 0.01% | 1266 |
|
|
2025
Q1 | $64.7M | Buy |
2,551,600
+294,800
| +13% | +$7.71M | 0.01% | 692 |
|
|
2024
Q4 | $59.9M | Buy |
2,256,800
+2,196,800
| +3,661% | +$59.6M | 0.01% | 758 |
|
|
2024
Q3 | $1.74M | Hold |
60,000
| – | – | ﹤0.01% | 3093 |
|
|
2024
Q2 | $1.68M | Hold |
60,000
| – | – | ﹤0.01% | 3034 |
|
|
2024
Q1 | $1.67M | Sell |
60,000
-76,100
| -56% | -$2.11M | ﹤0.01% | 3067 |
|
|
2023
Q4 | $3.92M | Buy |
136,100
+37,400
| +38% | +$1.13M | ﹤0.01% | 2459 |
|
|
2023
Q3 | $3.27M | Buy |
98,700
+25,000
| +34% | +$884K | ﹤0.01% | 2429 |
|
|
2023
Q2 | $2.7M | Buy |
+73,700
| New | +$2.87M | ﹤0.01% | 2601 |
|
|
2023
Q1 | – | Sell |
-630,000
| Closed | -$32.3M | – | 7376 |
|
|
2022
Q4 | $32.3M | Hold |
630,000
| – | – | 0.01% | 878 |
|
|
2022
Q3 | $27.6M | Hold |
630,000
| – | – | 0.01% | 888 |
|
|
2022
Q2 | $33M | Sell |
630,000
-200,000
| -24% | -$10.2M | 0.01% | 832 |
|
|
2022
Q1 | $43M | Buy |
830,000
+245,000
| +42% | +$12.7M | 0.01% | 818 |
|
|
2021
Q4 | $34.5M | Buy |
585,000
+515,000
| +736% | +$25.5M | 0.01% | 1041 |
|
|
2021
Q3 | $3.01M | Hold |
70,000
| – | – | ﹤0.01% | 2741 |
|
|
2021
Q2 | $2.74M | Sell |
70,000
-8,000
| -10% | -$311K | ﹤0.01% | 2785 |
|
|
2021
Q1 | $2.83M | Sell |
78,000
-238,800
| -75% | -$8.48M | ﹤0.01% | 2729 |
|
|
2020
Q4 | $11.7M | Sell |
316,800
-412,041
| -57% | -$15.1M | ﹤0.01% | 1604 |
|
|
2020
Q3 | $25.4M | Buy |
728,841
+26,455
| +4% | +$928K | 0.01% | 942 |
|
|
2020
Q2 | $21.8M | Buy |
702,386
+396,726
| +130% | +$13.5M | 0.01% | 990 |
|
|
2020
Q1 | $9.47M | Sell |
305,660
-72,094
| -19% | -$2.46M | ﹤0.01% | 1384 |
|
|
2019
Q4 | $14M | Hold |
377,754
| – | – | 0.01% | 1378 |
|
|
2019
Q3 | $12.9M | Sell |
377,754
-84,952
| -18% | -$3.09M | 0.01% | 1366 |
|
|
2019
Q2 | $19M | Buy |
462,706
+122,686
| +36% | +$4.87M | 0.01% | 1124 |
|
|
2019
Q1 | $13.7M | Sell |
340,020
-206,057
| -38% | -$8.25M | 0.01% | 1304 |
|
|
2018
Q4 | $22.6M | Buy |
546,077
+41,316
| +8% | +$1.72M | 0.01% | 917 |
|
|
2018
Q3 | $21.1M | Sell |
504,761
-120,261
| -19% | -$4.63M | 0.01% | 1097 |
|
|
2018
Q2 | $21.5M | Sell |
625,022
-132,699
| -18% | -$4.53M | 0.01% | 1029 |
|
|
2018
Q1 | $25.5M | Sell |
757,721
-382,180
| -34% | -$13.1M | 0.01% | 935 |
|
|
2017
Q4 | $39.2M | Buy |
1,139,901
+191,301
| +20% | +$6.52M | 0.02% | 738 |
|
|
2017
Q3 | $32.1M | Sell |
948,600
-110,670
| -10% | -$3.56M | 0.02% | 793 |
|
|
2017
Q2 | $33.8M | Buy |
1,059,270
+537,540
| +103% | +$17M | 0.02% | 734 |
|
|
2017
Q1 | $16.9M | Sell |
521,730
-1,964,656
| -79% | -$61.9M | 0.01% | 1133 |
|
|
2016
Q4 | $76.6M | Buy |
2,486,386
+1,422,268
| +134% | +$43.4M | 0.04% | 368 |
|
|
2016
Q3 | $34.2M | Buy |
1,064,118
+424,867
| +66% | +$14.2M | 0.02% | 681 |
|
|
2016
Q2 | $21.4M | Sell |
639,251
-577,487
| -47% | -$18.4M | 0.01% | 915 |
|
|
2016
Q1 | $34.2M | Sell |
1,216,738
-621,438
| -34% | -$17.8M | 0.02% | 624 |
|
|
2015
Q4 | $56.3M | Buy |
1,838,176
+1,005,938
| +121% | +$31.6M | 0.04% | 401 |
|
|
2015
Q3 | $24.8M | Buy |
832,238
+15,915
| +2% | +$510K | 0.02% | 653 |
|
|
2015
Q2 | $26M | Sell |
816,323
-1,796,965
| -69% | -$58.6M | 0.02% | 674 |
|
|
2015
Q1 | $86.3M | Buy |
2,613,288
+1,043,250
| +66% | +$33.2M | 0.06% | 227 |
|
|
2014
Q4 | $46.4M | Buy |
1,570,038
+289,850
| +23% | +$8.31M | 0.03% | 442 |
|
|
2014
Q3 | $35.9M | Buy |
1,280,188
+331,588
| +35% | +$9.31M | 0.02% | 504 |
|
|
2014
Q2 | $26.7M | Buy |
+948,600
| New | +$27M | 0.02% | 638 |
|
|
2014
Q1 | – | Sell |
-368,900
| Closed | -$10.7M | – | 6083 |
|
|
2013
Q4 | $10.7M | Buy |
368,900
+115,940
| +46% | +$3.37M | 0.01% | 1155 |
|
|
2013
Q3 | $6.89M | Sell |
252,960
-400,520
| -61% | -$10.9M | 0.01% | 1363 |
|
|
2013
Q2 | $17.4M | Buy |
+653,480
| New | +$18.1M | 0.01% | 739 |
|
Other funds holding PFE
VCM
VPM
Royal Bank of Canada's PFE Position: Q1 2026 in Review
Royal Bank of Canada reduced its Pfizer (PFE) stake by 4.8% in Q1 2026, selling an estimated $45.6M and leaving 34,155,840 shares worth $959M. The position accounts for 0.17% of the portfolio, ranked #114.
Royal Bank of Canada first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.63B in Q4 2021. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Royal Bank of Canada held 34,155,840 shares of Pfizer worth $959M as of Q1 2026.
- Royal Bank of Canada sold 1,714,429 Pfizer shares in Q1 2026, an estimated $45.6M.
- Pfizer made up 0.17% of Royal Bank of Canada's portfolio in Q1 2026, its #114 holding.
- Royal Bank of Canada first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Pfizer position peaked at $1.63B in Q4 2021.
- 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.